Fortrea Holdings Inc. is a global contract research organization that helps pharmaceutical, biotechnology, and medical device companies develop and bring new products to market. The company provides clinical trial management spanning all trial phases, clinical pharmacology services through four dedicated research units, and consulting on regulatory strategy and market access, with particular expertise in oncology, rare diseases, and cell and gene therapies. Fortrea serves a large and diversified customer base—including both large pharmaceutical firms and smaller biotechnology companies—through flexible service models (full-service, functional service provider, or hybrid), and generates revenue primarily from its clinical development business, which represents its largest revenue contributor.